Navigation Links
Nobles Medical Technologies II's NobleStitch EL Receives Strong Reviews from Physicians at Congenital & Structural Interventions Congress (CSI) in Frankfurt
Date:7/12/2013

Fountain Valley, California (PRWEB) July 12, 2013

Prof. Dr. Anthony Nobles, CEO of NMT2 also presented the NobleStitch at an all day symposium during the congress. More than 30 cardiologists participated in the all day one on one training sessions. Prof. Dr. Nobles commented, “the response from the cardiology community was overwhelming. The desire to close PFO’s for stroke and migraine was as strong as ever and the physicians unanimously agreed that closing with suture is a significant benefit over the umbrella “device” implant closure”.

Dr. Michael Mullen presented on his experience with the NobleStitch including his recent successful cases performed at the University College Hospital in London. Dr. Mullen commented “the NobleStitch system is potentially the best solution developed to date for PFO closure, this is the only system that can achieve closure without leaving a device behind”.

Ben Brosch, President of Nobles Medical II said, “This is the 4th year of presenting the evolution of the NobleStitch and now that we have entered the market, we are excited for the overwhelming response we received at the CSI”.

About Patent Foramen Ovale (PFO)
A PFO is a tunnel that exists between the left and right atrium of the heart. The tunnel, which is part of the normal fetal anatomy, should close shortly after birth. In 27% of the population the tunnel never closes. This tunnel can then allow clots and other chemicals to pass from the right to the left side of the heart freely bypassing the filter of the lungs. These clots and chemicals can cause strokes and other conditions such as severe migraines.

About the NobleStitch EL System
Nobles Medical Technologies II's NobleStitch EL is a catheter based system that allows a physician to place a suture in the PFO tunnel in the heart through a percutaneous puncture in the leg, in many cases under a local anesthetic in a catheter lab rather than an operating room. This eliminates the need for open-heart surgery or placement of a large metallic implant in the heart. The NobleStitch is not a “device” or mechanical implant it only places a simple polypropylene suture in the heart. By closing the hole or PFO, the therapy will reduce or eliminate the shunting from the right to the left side of the heart allowing the lungs to filter the clots and other chemicals from making it to the brain, potentially halting strokes and severe migraines and enabling patients to live a higher-quality life.

About Nobles Medical Technologies II
Nobles Medical Technologies II is a global structural heart company devoted to improving life through the development of its products and technologies. Nobles Medical Technologies II is focused on suture based solutions for the septum.

Visit Nobles Medical Technologies II http://www.noblesmedicaltechnology.com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10918861.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nobles Medical Technologies II's NobleStitch EL begins Sales in Europe
2. Physician Groups Call for Fewer Medical Tests
3. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
4. CAM therapy combined with conventional medical care may improve treatment of lower back pain
5. Image share project gives patients and physicians anytime, anywhere access to medical images
6. Researchers determine vitamin D blood level for reducing major medical risks in older adults
7. Biomedical researchers receive Hartwell Foundation awards
8. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
9. Fitness in Middle Age Lowers Medical Costs Later: Study
10. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
11. Gene Tests May Not Drive Patients to More Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: